| Trial ID: | L0687 |
| Source ID: | JPRN-UMIN000001266
|
| Associated Drug: |
Ezetimibe
|
| Title: |
|
| Acronym: |
--
|
| Status: |
--
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic steatohepatitis
|
| Interventions: |
administration of ezetimibe (10mg daily) in 24 weeks.
|
| Outcome Measures: |
Before and after 6 months of ezetimibe (10mg daily) to nonalcoholic statohepatitis (NASH) patients, we assessed liver lipid-metabolite alteration for use minute lipid analyzer: LipoSEARCH.we compared with hepatic histologic features,
|
| Sponsor/Collaborators: |
Division of Gastroenterology, Yokohama City University Hospital
|
| Gender: |
All
|
| Age: |
20years-old80years-old
|
| Phases: |
Phase 3
|
| Enrollment: |
10
|
| Study Type: |
Interventional
|
| Study Designs: |
Single arm Non-randomized
|
| Start Date: |
25/07/2008
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
2 April 2019
|
| Locations: |
Japan
|
| URL: |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001541
|
